SCHEMBL18200633

SCHEMBL18200633

c1ccc2cc(-c3ccc4cc(-c5nc6ccccc6c6c5ccc5ccccc56)ccc4c3)ccc2c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK8 P45983 1/20 0.42
MAPK9 P45984 1/20 0.42
MAPK10 P53779 1/20 0.42
LMNA P02545 2/20 0.41
MAPT P10636 2/20 0.41
HTT P42858 2/20 0.41
KDM4E B2RXH2 1/20 0.41
POLB P06746 1/20 0.41
HSP90AA1 P07900 1/20 0.41
GAA P10253 1/20 0.41
PKM P14618 1/20 0.41
GRK6 P43250 1/20 0.41
ADORA2A P29274 2/20 0.41
ADORA1 P30542 2/20 0.41
DHODH Q02127 1/20 0.40
HTR2B P41595 1/20 0.40
HTR5A P47898 1/20 0.40
ESR1 P03372 3/20 0.40
ESR2 Q92731 3/20 0.40
CYP17A1 P05093 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18200645 0.98 MAPK8 (0.43) MAPK8MAPK9MAPK10LMNAMAPT
SCHEMBL18200400 0.97 MAPK8 (0.40) MAPK8MAPK9MAPK10LMNAMAPT
SCHEMBL18200538 0.95 ESR1 (0.42) MAPK8MAPK9MAPK10KDM4EADORA2A
SCHEMBL18201033 0.95 ESR1 (0.42) MAPK8MAPK9MAPK10KDM4EADORA2A
SCHEMBL18200604 0.95 ESR1 (0.42) MAPK8MAPK9MAPK10KDM4EADORA2A
SCHEMBL18201075 0.92 ALDH1A1 (0.42) LMNAMAPTHTTKDM4EPOLB
SCHEMBL18200580 0.91 MEN1 (0.42) MAPK8MAPK9MAPK10LMNAMAPT
SCHEMBL18200519 0.89 KDM4E (0.40) LMNAMAPTHTTKDM4EPOLB
SCHEMBL18200364 0.89 KDM4E (0.40) LMNAMAPTHTTKDM4EPOLB
SCHEMBL18200416 0.89 MEN1 (0.52) MAPK8MAPK9MAPK10LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9728731-B2 Heterocyclic compound and organic light emitting device using same HEESUNG MATERIAL LTD. (KR) 2017-08-08 US disclosed
US-9728731-B2 Heterocyclic compound and organic light emitting device using same HEESUNG MATERIAL LTD. (KR) 2017-08-08 US disclosed
US-20160380208-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME HEESUNG MATERIAL LTD. (KR) 2016-12-29 US disclosed
EP-3088392-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME Heesung Material Ltd. (KR) 2016-11-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160380208-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME NOTUM, DDT, CRY1 MAPK8 3835/4885MAPK9 3843/4885MAPK10 4523/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.